• Download mobile app
25 Jul 2024, Edition - 3299, Thursday

Trending Now

  • No State was left out. Because the names of the States were not mentioned in the budget, it does not mean they were not considered: Finance Minister Nirmala Seetharaman
  • Vijay’s party, TVK ‘s first Manadu is likely to be held in Trichy.
  • If TN’s name should have come in the budget then the NDA should have got 25 MPs in the State: Anbumani Ramdoss


Twist Bioscience Accelerates Global Expansion with Strategic Asia Pacific Distribution Agreements

by businesswireindia.com

Business Wire India

Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced that the company has expanded its presence in Asia Pacific, adding strategic distribution partners for synthetic DNA (genes, gene fragment, oligo pool product lines) as well as the exome and custom target enrichment product suite for next-generation sequencing.

“The synthetic biology and next-generation sequencing markets are growing rapidly in Asia Pacific, and we are now poised to serve customers in Japan, Korea, India and Hong Kong,” said Emily M. Leproust, Ph.D., CEO of Twist Bioscience. “Building on our solid foundation in the United States and Europe, we are extending our global footprint by leveraging selected distributors with strong commercial presence and deep ties to our potential customers in these important geographies.”

Related to this expansion, Twist Bioscience has entered into distribution agreements with Recenttec K.K. in Japan; DNA Link and its subsidiary LnCBio Inc. in Korea; Premas Life Sciences in India; and, BioArrow Technology Limited in Hong Kong and Macau. Each organization will be responsible for distributing Twist Bioscience’s products in their respective geographies.

Recenttec K.K. Selected as Twist Bioscience’s Distribution Partner for Japan

Recenttec K.K. is a company based in Tokyo, Japan that provides products made in Taiwan, Europe and the U.S. including research reagents, equipment and consumables to the life science research market. Through alliances with industry leaders, Recenttec K.K. aims to expand sales in the Japanese market, extend customer satisfaction and become a valuable partner.

“In Japan, our life sciences customers value tools that allow them to conduct their research more efficiently,” said Takashi Hirahara, CEO of Recenttec. “We look forward to improving research and development efforts in the Japanese marketplace by bringing synthetic DNA products made using Twist Bioscience’s innovative platform to the market.”

LnCBio Inc., Subsidiary of DNA Link Inc., Selected as Twist Bioscience’s Distribution Partner for South Korea

Established in 2007, LnCBio Inc. has been supplying world leading instruments, consumables and service to molecular research and diagnostics market. With 10 years of excellent business performance and qualified technical support, LnCBio Inc. is one of the leading distributor companies in the biotechnology field in South Korea. LnCBio Inc. is a subsidiary of DNA Link Inc., a genomics service provider based in South Korea. Since its establishment in 2000, DNA Link has participated in numerous government/academia-sponsored research projects and became one of the main players in the genomics field. Recently, DNA Link is expanding its business area to precision medicine with patient-derived xenograft service, non-invasive prenatal testing service, and prognostic/predictive diagnostic test services for early stage breast cancer patients, preparing to take a leap forward from a service provider to precision medicine healthcare expert.

“We have been serving the synthetic biology and next-generation sequencing market for more than 15 years, with trusted relationships across South Korea,” stated Dr. Jong Eun Lee, CEO of DNA Link. “We look forward to offering Twist Bioscience’s suite of improved solutions for multiple market opportunities to customers we’ve served reliably for many years.”

BioArrow Technology Limited Selected as Twist Bioscience’s Distribution Partner for Hong Kong and Macau

BioArrow Technology Limited was established in Hong Kong in 2017. Its primary focused region is Hong Kong and Macau. The shareholders and top management team have shared the same core values in many aspects in the business areas of life sciences and clinical diagnostics. BioArrow uses professionals to serve professionals with integrity and trust, with a strong team consisting of expertise in molecular biology to support business in genomic research, molecular diagnostics and other related developing fields.

“We are confident that with the committed team and supportive business partners, BioArrow Technology Limited will grow into further success in the life sciences and clinical diagnostics with Twist Bioscience Corporation,” commented Alson Yang, Director of BioArrow Technology.

Premas Lifesciences Selected as Twist Bioscience’s Distribution Partner for India

Premas Lifesciences is a knowledge driven boutique partner for a range of specialized technologies in the field of life science, genomics, cell biology, bio banking and other related applications. The company prides itself in establishing concepts in the nascent markets which became industry norm.

“Partnering with rapidly-growing companies to expand their reach within India is our specialty at Premas Lifesciences, and we look forward to bringing the power of synthetic biology to India to fuel new and differentiated research in a timely fashion,” said Praveen Gupta, managing director of Premas.

About Twist Bioscience Corporation

At Twist Bioscience Corporation, we work in service of customers who are changing the world for the better. In fields such as health care, agriculture, industrial chemicals, academic research and data storage, by using our synthetic DNA tools, our customers are developing ways to better lives and improve the sustainability of the planet. We believe that the faster our customers succeed, the better for all of us, and we believe Twist Bioscience is uniquely positioned to help accelerate their efforts.

Our innovative silicon-based DNA synthesis platform provides precision at a scale that we believe is otherwise unavailable to our customers. Our platform technologies overcome inefficiencies and enable cost-effective, rapid, precise, high-throughput synthesis and sequencing, providing both the quality and quantity of the tools they need to rapidly realize the opportunity ahead. For more information about our products and services, please visit www.twistbioscience.com. Twist Bioscience is on Twitter. Sign up to follow our Twitter feed @TwistBioscience at https://twitter.com/TwistBioscience




Source: Businesswire